361 related articles for article (PubMed ID: 25071337)
21. Use of antiosteoporotic drugs and calcium/vitamin D in patients with fragility fractures: impact on re-fracture and mortality risk.
Degli Esposti L; Girardi A; Saragoni S; Sella S; Andretta M; Rossini M; Giannini S;
Endocrine; 2019 May; 64(2):367-377. PubMed ID: 30515678
[TBL] [Abstract][Full Text] [Related]
22. Calcium plus vitamin D supplementation and risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation.
Weaver CM; Alexander DD; Boushey CJ; Dawson-Hughes B; Lappe JM; LeBoff MS; Liu S; Looker AC; Wallace TC; Wang DD
Osteoporos Int; 2016 Jan; 27(1):367-76. PubMed ID: 26510847
[TBL] [Abstract][Full Text] [Related]
23. High prevalence of missed opportunities for secondary fracture prevention in a regional general hospital setting in Singapore.
Gani L; Reddy SK; Alsuwaigh R; Khoo J; King TFJ
Arch Osteoporos; 2017 Dec; 12(1):60. PubMed ID: 28656564
[TBL] [Abstract][Full Text] [Related]
24. The burden of osteoporosis in Brazil.
Marinho BC; Guerra LP; Drummond JB; Silva BC; Soares MM
Arq Bras Endocrinol Metabol; 2014 Jul; 58(5):434-43. PubMed ID: 25166033
[TBL] [Abstract][Full Text] [Related]
25. Cost-effectiveness of bisphosphonates for prevention of fracture related to glucocorticoid-induced osteoporosis in Malaysia.
Mohd-Tahir NA; Thomas P; Mohamed-Said MS; Makmor-Bakry M; Li SC
Int J Rheum Dis; 2018 Mar; 21(3):647-655. PubMed ID: 29105349
[TBL] [Abstract][Full Text] [Related]
26. The role of calcium supplementation in healthy musculoskeletal ageing : An expert consensus meeting of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Foundation for Osteoporosis (IOF).
Harvey NC; Biver E; Kaufman JM; Bauer J; Branco J; Brandi ML; Bruyère O; Coxam V; Cruz-Jentoft A; Czerwinski E; Dimai H; Fardellone P; Landi F; Reginster JY; Dawson-Hughes B; Kanis JA; Rizzoli R; Cooper C
Osteoporos Int; 2017 Feb; 28(2):447-462. PubMed ID: 27761590
[TBL] [Abstract][Full Text] [Related]
27. The efficacy of pharmacotherapy in postmenopausal osteoporosis: a longitudinal observational study.
Pluskiewicz W; Adamczyk P; Franek E; Sewerynek E; Wichrowska H; Napiórkowska L; Stuss M; Rozwandowicz A; Drozdzowska B
Endokrynol Pol; 2019; 70(6):473-477. PubMed ID: 31909456
[TBL] [Abstract][Full Text] [Related]
28. Prevention of bone loss and vertebral fractures in patients with chronic epilepsy--antiepileptic drug and osteoporosis prevention trial.
Lazzari AA; Dussault PM; Thakore-James M; Gagnon D; Baker E; Davis SA; Houranieh AM
Epilepsia; 2013 Nov; 54(11):1997-2004. PubMed ID: 24010637
[TBL] [Abstract][Full Text] [Related]
29. Bone Metabolism Impairment in Heart Transplant: Results From a Prospective Cohort Study.
Seguro LFBC; Pereira RMR; Seguro LPC; Caparbo VF; Avila MS; Mangini S; Campos IW; Gaiotto FA; Marcondes-Braga FG; Bacal F
Transplantation; 2020 Apr; 104(4):873-880. PubMed ID: 31403557
[TBL] [Abstract][Full Text] [Related]
30. A Practical Approach to Children with Recurrent Fractures.
Korula S; Titmuss AT; Biggin A; Munns CF
Endocr Dev; 2015; 28():210-225. PubMed ID: 26138844
[TBL] [Abstract][Full Text] [Related]
31. Vitamin D and bone fracture mechanisms: what about the non-bone 'D'efense?
Annweiler C; Beauchet O
Int J Clin Pract; 2010 Apr; 64(5):541-3. PubMed ID: 20456208
[TBL] [Abstract][Full Text] [Related]
32. Use of calcium supplements, vitamin D supplements and specific osteoporosis drugs among French women aged 75-85 years: patterns of use and associated factors.
Castro-Lionard K; Dargent-Molina P; Fermanian C; Gonthier R; Cassou B
Drugs Aging; 2013 Dec; 30(12):1029-38. PubMed ID: 24114665
[TBL] [Abstract][Full Text] [Related]
33. HIV infection and osteoporosis: pathophysiology, diagnosis, and treatment options.
Rothman MS; Bessesen MT
Curr Osteoporos Rep; 2012 Dec; 10(4):270-7. PubMed ID: 23100110
[TBL] [Abstract][Full Text] [Related]
34. Orthopedic-Metabolic Collaborative Management for Osteoporotic Hip Fracture.
Rotman-Pikielny P; Frankel M; Lebanon OT; Yaacobi E; Tamar M; Netzer D; Nabriski D; Nyska M; Brin YS
Endocr Pract; 2018 Aug; 24(8):718-725. PubMed ID: 30084682
[TBL] [Abstract][Full Text] [Related]
35. Calcium and vitamin D nutrition and bone disease of the elderly.
Gennari C
Public Health Nutr; 2001 Apr; 4(2B):547-59. PubMed ID: 11683549
[TBL] [Abstract][Full Text] [Related]
36. Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a position statement from the Swiss Association against Osteoporosis.
Biver E; Calmy A; Aubry-Rozier B; Birkhäuser M; Bischoff-Ferrari HA; Ferrari S; Frey D; Kressig RW; Lamy O; Lippuner K; Suhm N; Meier C
Osteoporos Int; 2019 May; 30(5):1125-1135. PubMed ID: 30603840
[TBL] [Abstract][Full Text] [Related]
37. Short-term and long-term effects of osteoporosis therapies.
Reid IR
Nat Rev Endocrinol; 2015 Jul; 11(7):418-28. PubMed ID: 25963272
[TBL] [Abstract][Full Text] [Related]
38. Barriers to secondary fracture prevention in primary care.
Mendis AS; Ganda K; Seibel MJ
Osteoporos Int; 2017 Oct; 28(10):2913-2919. PubMed ID: 28664275
[TBL] [Abstract][Full Text] [Related]
39. [Age and osteoporosis. Effects of aging on osteoporosis, the diagnostics and therapy].
Jakob F; Seefried L; Schwab M
Internist (Berl); 2014 Jul; 55(7):755-61. PubMed ID: 24903137
[TBL] [Abstract][Full Text] [Related]
40. Bone health and vitamin D status in alcoholic liver disease.
Kizilgul M; Ozcelik O; Delibasi T
Indian J Gastroenterol; 2016 Jul; 35(4):253-9. PubMed ID: 27246833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
